NEW YORK (Reuters) -The U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services on Thursday sent the White House the details of a drug pricing pilot for official review, according to a government website.
The pilot, titled Global Benchmark for Efficient Drug Pricing (GLOBE) Model, will need to be cleared by the White House’s Office of Management and Budget before it is implemented.
HHS did not immediately respond to a request for comment.
(Reporting by Patrick Wingrove, Editing by Franklin Paul)
Comments